CD90 anticorps (N-Term)
-
- Antigène Voir toutes CD90 (THY1) Anticorps
- CD90 (THY1)
-
Épitope
- AA 36-65, N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CD90 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Purification
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Immunogène
- This THY1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 36-65 amino acids from the N-terminal region of human THY1.
- Clone
- RB03970
- Isotype
- Ig Fraction
- Top Product
- Discover our top product THY1 Anticorps primaire
-
-
- Indications d'application
- WB: 1:1000. WB: 1:1000. IHC-P: 1:50~100. IHC-P: 1:10~50. IHC-P: 1:50~100
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
- Date de péremption
- 6 months
-
-
The clinical pathological significance of Thy1 and CD49f expression in chondrosarcomas." dans: Pathology, research and practice, Vol. 212, Issue 7, pp. 636-42, (2017) (PubMed).
: "Quantitative Analysis of Differential Proteome Expression in Bladder Cancer vs. Normal Bladder Cells Using SILAC Method." dans: PLoS ONE, Vol. 10, Issue 7, pp. e0134727, (2015) (PubMed).
: "Analogy between sphere forming ability and stemness of human hepatoma cells." dans: Oncology reports, Vol. 24, Issue 5, pp. 1147-51, (2011) (PubMed).
: "High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma." dans: Gut, Vol. 59, Issue 7, pp. 953-62, (2010) (PubMed).
: "
-
The clinical pathological significance of Thy1 and CD49f expression in chondrosarcomas." dans: Pathology, research and practice, Vol. 212, Issue 7, pp. 636-42, (2017) (PubMed).
-
- Antigène
- CD90 (THY1)
- Autre désignation
- THY1 (THY1 Produits)
- Synonymes
- anticorps CD90, anticorps CD7, anticorps T25, anticorps Thy-1, anticorps Thy-1.2, anticorps Thy1.1, anticorps Thy1.2, anticorps Thy-1 cell surface antigen, anticorps thymus cell antigen 1, theta, anticorps THY1, anticorps Thy1
- Sujet
- THY1 (CD90) antigen is a GPI linked glycoprotein member of the Immunoglobulin superfamily. It is expressed on murine T cells, thymocytes, neural cells, cells of granulocytic lineage, early hematopoietic progenitors, fibroblasts, neurons and Kupffer's cells. Thy1 may play a role in cell to cell or cell to ligand interactions during synaptogenesis and other events in the brain.
- Poids moléculaire
- 17935
- ID gène
- 7070
- NCBI Accession
- NP_006279
- UniProt
- P04216
- Pathways
- Cell-Cell Junction Organization
-